NKGen Biotech (Graf Acquisition IV) ^{Priced, NYSE: NKGN}

We are a newly organized blank check company. We intend to focus our search on businesses that may provide significant opportunities for attractive investor returns. Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region and may include, without limitation, targets in industries such as mobility, technology, transportation, new energy, software, business real estate services, financial and data services, healthcare, diversified industrial manufacturing, technology, distribution and services, as well as companies that help to address evolving environmental, social and governance ("ESG") related issues. We will seek to capitalize on the significant experience and relationships of James A. Graf, our Chief Executive Officer, Anthony A. Kuznik, our Executive Vice President and General Counsel and the other members of our management team in identifying and consummating an initial business combination. Mr. Graf has served as a founder and executive officer or as a director of five special purpose acquisition companies, including as chief executive officer of Graf Industrial Corp., or Graf I, from June 2018 until the closing of its business combination with Velodyne Lidar, Inc. in September 2020.